Literature DB >> 165766

Regulation of theta-antigen expression by agents altering cyclic AMP level and by thymic factor.

M A Bach, C Fournier, J F Bach.   

Abstract

Thymic factor, cyclic AMP, and products increasing its cellular level, such as Prostaglandin E1, induce the appearance of the theta-antigen on T-cell precursors whether assessed by a rossette-inhibition assay or a cytotoxic assay after cell fractionation on BSA discontinuous gradiet. Synergism has been demonstrated between cyclic AMPT and TF for that effect. Conversely, decrease of theta expression has been obtained by altering cyclic AMP level in theta-positive cells either increasing it by dibutyryl cAMP treatment or decreasing it by indomethacin treatment. Finally, these data suggest the involvement of cyclic AMP in the regulation of theta expression under thymic hormone control.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165766     DOI: 10.1111/j.1749-6632.1975.tb29079.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

1.  Augmentation of mitogen responsiveness in human lymphocytes by a humoral factor obtained from thymic epithelial cultures.

Authors:  E J Hensen; E C Hoefsmit; J G Van Den Tweel
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330

2.  New approaches to immunotherapy: thymomimetic drugs.

Authors:  S Specter; J W Hadden
Journal:  Springer Semin Immunopathol       Date:  1985

3.  The clinical use of monoclonal anti-T-cell antibodies.

Authors:  J F Bach; L Chatenoud
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

4.  Suppression of acute experimental allergic encephalomyelitis by synthetic serum thymic factor. Clinical, histopathological, and immunohistochemical studies.

Authors:  S Kato; H Nakamura
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

5.  Age-related changes in human thymus.

Authors:  J Singh; A K Singh
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

6.  Evaluation of functional thymic hormones in Arabian horses with severe combined immunodeficiency.

Authors:  G A Splitter; G Incefy; T Iwata; T C McGuire
Journal:  Clin Exp Immunol       Date:  1979-10       Impact factor: 4.330

7.  Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.

Authors:  S Erdogan; M D Houslay
Journal:  Biochem J       Date:  1997-01-01       Impact factor: 3.857

Review 8.  Regulation of the immune response by prostaglandins.

Authors:  J S Goodwin; J Ceuppens
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

9.  Lymphocyte adherence in multiple sclerosis: effect of aspirin.

Authors:  P Dore-Duffy; R B Zurier
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.